Advertisement

Topics

Carl Zeiss Meditec AG AFX Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

11:06 EDT 22 Jun 2017 | BioPortfolio Reports

Carl Zeiss Meditec AG AFX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Carl Zeiss Meditec AG Carl Zeiss Meditec, a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of eye diseases including implants and consumable materials. Its major products include medical laser and diagnostic systems, intraocular lenses and consumables for ophthalmic surgery. The company products find application in diagnosis, monitoring and follow up treatment of various diseases of the eye diseases. The company products are marketed through distribution companies and agencies in Europe, the Americas and AsiaPacific. Carl Zeiss Meditec is headquartered in Jena, Germany.

Carl Zeiss Meditec AG Key Recent Developments

Jun 07,2017: Salk's Waitt Advanced Biophotonics Center partners with imaging giant ZEISS
May 30,2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec
May 10,2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17
May 08,2017: Open Innovation of ZEISS and the Advanced Retina Imaging Network advances SweptSource OCT technology for better vision care
May 08,2017: ZEISS Appoints New Fellow

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Carl Zeiss Meditec AG AFX Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Carl Zeiss Meditec AG AFX Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...